Theriva Biologics, Inc. (TOVX)
NYSEAMERICAN: TOVX · Real-Time Price · USD
0.5672
+0.0072 (1.29%)
At close: May 14, 2025, 4:00 PM
0.5752
+0.0080 (1.41%)
After-hours: May 14, 2025, 8:00 PM EDT
Theriva Biologics Market Cap
Theriva Biologics has a market cap or net worth of $5.45 million as of May 14, 2025. Its market cap has decreased by -24.37% in one year.
Market Cap
5.45M
Enterprise Value
-4.60M
1-Year Change
-24.37%
Ranking
Category
Stock Price
$0.57
Market Cap Chart
Since April 2, 2007, Theriva Biologics's market cap has decreased from $81.60M to $5.45M, a decrease of -93.33%. That is a compound annual growth rate of -13.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2025 | 1.60M | -67.35% |
| Dec 31, 2024 | 4.90M | -32.88% |
| Dec 29, 2023 | 7.30M | 1.39% |
| Dec 30, 2022 | 7.20M | -79.94% |
| Dec 31, 2021 | 35.90M | 366.23% |
| Dec 31, 2020 | 7.70M | -9.41% |
| Dec 31, 2019 | 8.50M | 11.84% |
| Dec 31, 2018 | 7.60M | -88.36% |
| Dec 29, 2017 | 65.30M | -7.11% |
| Dec 30, 2016 | 70.30M | -66.19% |
| Dec 31, 2015 | 207.90M | 96.32% |
| Dec 31, 2014 | 105.90M | 55.05% |
| Dec 31, 2013 | 68.30M | -11.18% |
| Dec 31, 2012 | 76.90M | 116.62% |
| Dec 30, 2011 | 35.50M | 22.84% |
| Dec 31, 2010 | 28.90M | 140.83% |
| Dec 31, 2009 | 12.00M | 224.32% |
| Dec 31, 2008 | 3.70M | -96.22% |
| Dec 31, 2007 | 97.80M | 19.85% |
View and export this data all the way back to 2007.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 669.76B |
| Johnson & Johnson | 357.16B |
| AbbVie | 332.08B |
| Novo Nordisk | 291.59B |
| UnitedHealth Group | 282.47B |
| Abbott Laboratories | 224.53B |
| Novartis AG | 209.81B |
| AstraZeneca | 209.59B |